top of page
F.D.A. Approves New Treatment for Early Alzheimer’s

F.D.A. Approves New Treatment for Early Alzheimer’s

Newspaper article

Food and Drug Administration on January 7, 2023 approved another Alzheimer’s drug that may modestly slow the pace of cognitive decline early in the disease, but also carries risks of swelling and bleeding in the brain.

bottom of page